We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
-4%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.26B
AUM Growth
-$362M
Cap. Flow
-$5M
Cap. Flow %
-0.12%
Top 10 Hldgs %
43.71%
Holding
683
New
46
Increased
475
Reduced
93
Closed
17

Top Buys

Rank Stock Value
1
PM icon
Philip Morris
PM
+$38.3M
2
AMZN icon
Amazon
AMZN
+$27.7M
3
PLTR icon
Palantir
PLTR
+$17.5M
4
HIMS icon
Hims & Hers Health
HIMS
+$13.7M
5
YUMC icon
Yum China
YUMC
+$13.2M

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$39.4M
2
NVDA icon
NVIDIA
NVDA
+$30.1M
3
META icon
Meta Platforms (Facebook)
META
+$14.9M
4
BEKE icon
KE Holdings
BEKE
+$14.1M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$11.2M

Sector Composition

Rank Sector Weight
1 Technology 42.45%
2 Consumer Discretionary 16.26%
3 Communication Services 14.17%
4 Healthcare 8.06%
5 Consumer Staples 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LXP icon
426
LXP Industrial Trust
LXP
$3.57B
$48.3K ﹤0.01%
1,116
+46
+4% +$1.97K
AKR icon
427
Acadia Realty Trust
AKR
$3.09B
$47.5K ﹤0.01%
2,266
+352
+18% +$7.97K
ARQT icon
428
Arcutis Biotherapeutics
ARQT
$3.36B
$46.9K ﹤0.01%
2,996
+538
+22% +$7.58K
SUPN icon
429
Supernus Pharmaceuticals
SUPN
$2.59B
$46.3K ﹤0.01%
1,413
+254
+22% +$9K
KYMR icon
430
Kymera Therapeutics
KYMR
$8.51B
$45.4K ﹤0.01%
1,658
+298
+22% +$10.9K
UE icon
431
Urban Edge Properties
UE
$2.86B
$44.9K ﹤0.01%
2,365
+160
+7% +$3.2K
DVAX
432
DELISTED
Dynavax Technologies
DVAX
$43.7K ﹤0.01%
3,366
+606
+22% +$8.02K
CURB
433
Curbline Properties
CURB
$3.52B
$43.3K ﹤0.01%
1,791
+76
+4% +$1.83K
APGE icon
434
Apogee Therapeutics
APGE
$10.1B
$43.1K ﹤0.01%
1,153
+208
+22% +$8.04K
IVT icon
435
InvenTrust Properties
IVT
$2.76B
$42.9K ﹤0.01%
1,461
+59
+4% +$1.74K
AGIO icon
436
Agios Pharmaceuticals
AGIO
$1.79B
$42.8K ﹤0.01%
1,460
+263
+22% +$8.72K
CGON icon
437
CG Oncology
CGON
$6.28B
$42.4K ﹤0.01%
1,731
+311
+22% +$8.75K
PK icon
438
Park Hotels & Resorts
PK
$3.03B
$41.9K ﹤0.01%
3,919
+123
+3% +$1.56K
BEAM icon
439
Beam Therapeutics
BEAM
$2.63B
$41.4K ﹤0.01%
2,120
+381
+22% +$9.98K
ARWR icon
440
Arrowhead Research
ARWR
$11.9B
$40.6K ﹤0.01%
3,186
+573
+22% +$10.4K
BCRX icon
441
BioCryst Pharmaceuticals
BCRX
$2.28B
$39.8K ﹤0.01%
5,303
+954
+22% +$7.7K
TVTX icon
442
Travere Therapeutics
TVTX
$5.2B
$39.4K ﹤0.01%
2,198
+395
+22% +$8.02K
VERA icon
443
Vera Therapeutics
VERA
$2.3B
$38.9K ﹤0.01%
1,621
+291
+22% +$9.35K
IRON icon
444
Disc Medicine
IRON
$2.94B
$37.8K ﹤0.01%
762
+137
+22% +$7.62K
JANX icon
445
Janux Therapeutics
JANX
$925M
$36.3K ﹤0.01%
1,343
+241
+22% +$9.08K
IDYA icon
446
IDEAYA Biosciences
IDYA
$3.42B
$36.2K ﹤0.01%
2,213
+398
+22% +$8.48K
ANIP icon
447
ANI Pharmaceuticals
ANIP
$1.8B
$36K ﹤0.01%
538
+97
+22% +$5.79K
AMPH icon
448
Amphastar Pharmaceuticals
AMPH
$879M
$35.7K ﹤0.01%
1,230
+220
+22% +$7.03K
MNKD icon
449
MannKind Corp
MNKD
$1.21B
$35.5K ﹤0.01%
7,061
+1,270
+22% +$7.11K
SHO icon
450
Sunstone Hotel Investors
SHO
$2.19B
$34.1K ﹤0.01%
3,624
+114
+3% +$1.24K
16 17
18
19 20

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

GF Fund Management's Q1 2025 Portfolio in Review

As of Q1 2025, GF Fund Management held 683 positions worth $4.26B, down 7.8% from $4.62B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

GF Fund Management's Q1 2025 filing shows 46 new, 475 increased, 93 reduced and 17 closed positions. Its largest new stake was Hims & Hers Health: 368,661 shares worth $10.9M. The largest sale was Pinduoduo, an estimated $39.4M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 45% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • GF Fund Management's largest Q1 2025 buy was Hims & Hers Health: 368,661 shares worth $10.9M.
  • GF Fund Management added most to Philip Morris in Q1 2025, an estimated $38.3M increase.
  • GF Fund Management's biggest Q1 2025 reduction was Pinduoduo, cutting an estimated $39.4M.
  • GF Fund Management fully exited Applied Optoelectronics in Q1 2025, selling an estimated $5.07M.
  • GF Fund Management's ten largest holdings make up 44% of its $4.26B portfolio in Q1 2025.
  • GF Fund Management opened 46 new positions and closed 17 in Q1 2025.
  • GF Fund Management's portfolio value fell 7.8% quarter-over-quarter to $4.26B.

Based on GF Fund Management's 13F filing for Q1 2025, filed 29 Apr 2025.